Offer - Urjas Oil for just ₹ 1 X
Celneuro CD3 is an allopathic medicine The correct dosage of Celneuro CD3 depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Celneuro CD3 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Celneuro CD3 safe for pregnant women?
Celneuro CD3 is safe for pregnant women.
Is the use of Celneuro CD3 safe during breastfeeding?
Celneuro CD3 is completely safe for breastfeeding women.
What is the effect of Celneuro CD3 on the Kidneys?
Celneuro CD3 rarely affects the kidneys.
What is the effect of Celneuro CD3 on the Liver?
Celneuro CD3 can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Celneuro CD3 on the Heart?
There is no research available on the side effects of Celneuro CD3 on the heart. Therefore, its impact is unknown.
Celneuro CD3 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Celneuro CD3 unless your doctor advises you to do so -
Is this Celneuro CD3 habit forming or addictive?
Celneuro CD3 does not cause addiction.
Interaction between Food and Celneuro CD3
When consumed with certain foods, Celneuro CD3 may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Celneuro CD3
Information about the interaction of Celneuro CD3 and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 265-269
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 655
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alpha Lipoic Acid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1279